Clinical Study
Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy
Table 1
Clinical characteristics of 695 NPC.
| Characteristics | (%) |
| Age | | Median: 45 yrs | | Range: 14–74 | | ≤45 yrs | 449 (64.6) | >45 yrs | 246 (35.4) | Gender | | Male | 540 (77.7) | Female | 155 (22.3) | Histopathology (WHO type) | | Type 1 | 40 (5.7) | Types 2.1 & 2.2 | 655 (94.3) | T-classification | | T1 | 43 (6.1) | T2 | 229 (32.9) | T3 | 244 (35.1) | T4 | 179 (25.9) | N-classification | | N0 | 49 (7.1) | N1 | 228 (32.8) | N2 | 383 (55.1) | N3 | 35 (5.0) | Clinical stage | | I | 43 (6.1) | II | 172 (24.7) | III | 268 (38.6) | IV | 212 (30.6) | Chemotherapy | | Not given | 236 (34.0) | Concurrent | 190 (27.3) | Induction + concurrent | 52 (7.5) | Concurrent + adjuvant | 217 (31.2) |
|
|